We are live on ! Find out more
SONM icon

DNA X Inc
SONM

13 hedge funds and large institutions have $284K invested in DNA X Inc in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0.01% → 0.01% (-0%)

13% less funds holding

Funds holding: 15 → 13 (-2)

24% less capital invested

Capital invested by funds: $373K → $284K (-$88.5K)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

Holders
13
Holders Change
-2
Holders Change %
-13.33%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$52.4K
2
UBS Group
UBS Group
Switzerland
+$21.1K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$82
4
Wells Fargo
Wells Fargo
California
+$82

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$74K
2
VF
Virtu Financial
New York
-$7.32K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$7K
4
TSS
Two Sigma Securities
New York
-$7K
5
SFI
Susquehanna Fundamental Investments
Pennsylvania
-$5K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
1
Bank of New York Mellon
New York
$92.4K -$822 -10 -0.8%
Millennium Management
2
Millennium Management
New York
$66K +$52.4K +637 +283%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$31K -$82 -1 -0.2%
UBS Group
4
UBS Group
Switzerland
$19.9K +$21.1K +257 New
Renaissance Technologies
5
Renaissance Technologies
New York
$19K -$74K -900 -79%
Vanguard Group
6
Vanguard Group
Pennsylvania
$17.3K +$82 +1 +0.4%
VF
7
Virtu Financial
New York
$14K -$7.32K -89 -33%
State Street
8
State Street
Massachusetts
$9.94K – – –
Citigroup
9
Citigroup
New York
$7.48K – – –
Northern Trust
10
Northern Trust
Illinois
$7.3K – – –
Wells Fargo
11
Wells Fargo
California
$56 +$82 +1 New
EL
12
EMFO LLC
Florida
$42 – – –
Fidelity Investments
13
Fidelity Investments
Massachusetts
$40 -$4.52K -55 -98%
TSS
14
Two Sigma Securities
New York
– -$7K -79 Closed
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
– -$7K -77 Closed
SFI
16
Susquehanna Fundamental Investments
Pennsylvania
– -$5K -58 Closed
WAP
17
Wealthcare Advisory Partners
Pennsylvania
– -$5K -57 Closed

SONM Hedge Fund Activity: Q4 2022 in Review

13 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in DNA X Inc (SONM) for Q4 2022, worth a combined $284K — down 24% from $373K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of SONM and 2 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 2 added.

The largest buyer was Millennium Management, adding an estimated $52.4K. The largest seller was Renaissance Technologies, cutting an estimated $74K.

  • 13 institutional investors held DNA X Inc (SONM) as of Q4 2022, down from 15 in Q3 2022.
  • Funds reported $284K of DNA X Inc stock for Q4 2022, down 24% quarter-over-quarter.
  • 2 funds opened new DNA X Inc positions in Q4 2022 and 4 closed out, a net change of -2 holders.
  • The largest DNA X Inc buyer in Q4 2022 was Millennium Management, an estimated $52.4K added.
  • The largest DNA X Inc seller in Q4 2022 was Renaissance Technologies, an estimated $74K sold.

Based on aggregated 13F filings for Q4 2022.